Reposted from the NIH Extramural Nexus newsletter October 21, 2020 Update: NIH Will Continue to Accept Preliminary Data as Post-Submission Material Through August/October 2021 Councils In recognition of the fact that COVID-19 may still be adversely affecting the ability of applicants to generate preliminary data, NIH will continue to accept…

Reposted from the NIH Extramural Nexus newsletter Posted on November 9, 2020 by Mike Lauer Stephen I. Katz, M.D., Ph.D., led the National Institute of Arthritis and Musculoskeletal Diseases from 1995 until his passing in 2018. Dr. Katz was a talented physician scientist, NIH leader, and civil servant throughout…

The NIH continues to add new resources to their COVID-19: Information for NIH Applicants and Recipients of NIH Funding webpage. They hope they are helpful in navigating this unprecedented situation. Here is a summary of what’s new since the last Nexus: Updated infographic describing the peer review process…

Environmental Health & Safety is open and continues to provide critical services and assistance to the research community. New training video, research resumption checklist and signs/posters posted on their COVID resources page: More information: http://www.ehs.ufl.edu/resources/covid-19/   The Screen, Test & Protect initiative uses public health guidance and best practices aimed…

Urgent public health measures are needed to control the spread of the novel coronavirus (SARS-CoV-2) and the disease it causes, coronavirus disease 2019, or COVID-19. Scientific research to improve our understanding of the virus and how it causes disease, and to develop strategies to mitigate illness and death, is of…

Sent on behalf of Dr. Sharon Milgram: Dear All: I hope you are well. Here are updates from the NIH OITE, including 1) the schedule of webinars for next week (somewhat abbreviated because we have our virtual postbac poster day and it is our first experience with 900 posters in…

Posted on April 13, 2020 by Mike Lauer, NIH Deputy Director for Extramural Research As you can imagine, NIH is devoting significant resources to COVID-19. In addition to dedicating regularly appropriated funds, to date NIH has received emergency funding for COVID-19-related activities in two supplemental bills (available from…

The NIH is deeply concerned for the health and safety of people involved in NIH research, and about the effects on the biomedical enterprise in the areas affected by the HHS declared public health emergency for COVID-19. Due to the potential exceptional impact, we want to assure our recipient…

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-20-082.html Purpose It is likely that the emergency declaration related to novel coronavirus (COVID-19) will adversely affect some NIH applicants’ and recipients’ ability to submit applications in a timely manner. Late applications When delays occur because the applicant or recipient organization is officially closed or unable to submit grant…

NIH Policy NOT-OD-16-148 (https://grants.nih.gov/grants/guide/notice-files/not-od-16-148.html) requires all NIH-funded investigators and staff who are involved in the conduct, oversight, or management of clinical trials (biomedical or behavioral) to be trained in Good Clinical Practice (GCP). The NIH definition of a clinical trial is “a research study in which one or…